Recent Company News

• 10:53 PM ET May 08, 2025
  

  Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved

• 10:53 PM ET May 08, 2025
  

  Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City

• 05:17 PM ET May 07, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:35 AM ET May 07, 2025
  

  MedinCell shares UZEDY update (€15.43, +0.03)

• 09:17 AM ET May 07, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:56 AM ET May 07, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:18 AM ET May 07, 2025
  

  StreetAccount Summary - US Pre-market trading

• 07:29 AM ET May 07, 2025
  

  Wednesday AM conference calls - Healthcare

• 07:11 AM ET May 07, 2025
  

  StreetAccount Metrics Recap - Teva Pharmaceutical Q1 Earnings ($16.12, 0.00)

• 07:04 AM ET May 07, 2025
  

  Teva Pharmaceutical reports Q1 EPS $0.52 ex-items vs FactSet $0.46 [4 est, $0.41-0.50] ($16.12, 0.00)